Skip to main content
ARCT logo

ARCT · Arcturus Therapeutics Holdings Inc. · Holdings

Track ARCT — free
$7.45 -0.15 (-1.97%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$214.73M
Shares
28.82M
Volume · Nov 20 602K Avg daily vol (3M) 883.08K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 158
Total Value: $346,383,768
Total Shares: 25,301,963
Showing 1–100 of 163 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Share of 13F common-share value, across 158 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
11.8%
Dec 2023 → Sep 2026 · range 11.8% – 18.5%
−1.4 pts
Top 5
42.5%
Dec 2023 → Sep 2026 · range 42.5% – 54.6%
−8.5 pts
Top 10
61.8%
Dec 2023 → Sep 2026 · range 61.8% – 74.3%
−7.3 pts
HHI
510
Dec 2023 → Sep 2026 · range 510 – 771
Broadly held−134

Who Holds ARCT

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 155 filers, like-for-like change +1.2%; actively managed books +3.2%; index-like books -3.0%.

Holder type Share Filers Change
Registered adviser 49.7% 76 +3.7%
Exempt adviser 0.7% 3 -35.4%
Adviser 9.8% 5 -35.2%
Bank 15.3% 13 +8.2%
Broker-dealer 0.5% 2 new
Benefit plan 0.0% 2 -67.3%
Non-US 1.2% 3 -0.2%
Holding company 13.0% 7 +7.4%
Insurer 0.0% 0 —
Unknown 9.7% 44 +39.6%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F and 1 holder with no observed 2026-09-30 13F.

Conviction and Crowding

155 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
0
0.000% of filers hold it in their top 10
Jun 30, 2026: 0
Holders above 5%
0
median weight 0.000%
Jun 30, 2026: 0
Crowding
33.5%
of shares outstanding, 85th percentile
Jun 30, 2026: 27.2%
Private-fund advisers
28.1%
of shares outstanding
Institutional ownership
89.0%
91.1% of the estimated free float
Top 10 holders
61.8%
of 13F shares, Herfindahl 0.051
Active holders
+3.2%
like-for-like share change of active filers
5% stakes on record
6
0 13D, 6 13G (6 institutional, 0 passive, 0 exempt)
How long holders have held it value-weighted 16.8 quarters
Under 1 year 17.4% 1 to 3 years 23.3% 3 years or more 59.4% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $3,634,537 (2 buying, 4 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$18.23
estimated per share
Jun 30, 2026: $23.37
Quarter-end price
$13.69
implied by 13F values
Estimated gain or loss
-24.9%
price against the estimated cost
Estimated at a loss
32.3%
of costed 13F value

Estimated cost covers 44.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies ARCT's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 CERS Cerus Corp 3
2 WRD WeRide Inc. 3
3 PRME Prime Medicine, Inc. 3
4 PONY Pony AI Inc. 3
5 RXRX Recursion Pharmaceuticals, Inc. 3
6 LUNR Intuitive Machines, Inc. 3
7 CRSP CRISPR Therapeutics AG 4
8 XE X-Energy, Inc. 3
9 CMPS COMPASS Pathways plc 3
10 JOBY Joby Aviation, Inc. 3

Shareholder Targets

13F filers that own its peers but not ARCT, quarter ended Sep 30, 2026

Found through its holder-overlap peers: CERS, WRD, PRME, PONY, RXRX, LUNR, CRSP, XE, CMPS, JOBY, TEM, TXG, GTLB, AUR, ACHR, TWST, RKLB, RBRK, GH, CBRS. 2,150 filers in all.

# Filer In peers
1 T. Rowe Price Investment Management, Inc. Adviser, Diversified active $2,727,292,648 8 held
2 BAILLIE GIFFORD & CO Adviser, Diversified active $2,584,608,470 10 held
3 Capital World Investors Adviser, Diversified active $1,738,917,989 5 held
4 Capital International Investors Adviser, Diversified active $1,506,424,948 4 held
5 CITADEL ADVISORS LLC Registered adviser, Systematic-like $1,163,229,668 19 held
6 Altimeter Capital Management, LP Registered adviser, Concentrated $1,057,639,985 1 held
7 FIRST TRUST ADVISORS LP Registered adviser, Diversified active $979,588,939 13 held
8 Uber Technologies, Inc Unknown, Concentrated $972,983,799 3 held
9 VOYA INVESTMENT MANAGEMENT LLC Registered adviser, Diversified active $972,558,398 16 held
10 ECLIPSE OPERATIONS, LLC Exempt adviser, Unknown $940,163,238 1 held

Fund Ownership of ARCT by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 13.36% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.21% 924,269
Index ETFs 10.15% 2,925,657
Active ETFs 10.29% 2,964,484
Active funds 16.03% 4,621,571
Unclassified 0.40% 113,960
All registered funds 40.07% 11,549,941
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
32
Increased
60
Decreased
49
Sold Out
13
Unchanged
15

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +20
Institutional value: +106.1%
Shares held: +1.2%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 163
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 163 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1768224 CUSIP 03969T109 13F (30d) 172 filings 143 filers Visit website Investor relations